http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101641101-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_083f0472b0a1ad0b6b017a43bd472db5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 |
| filingDate | 2008-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35d1b847edafb12e721a9cdad3ec002f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfb410a54fd588a1e87bb29bc24f04cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d539aca3963cae9db2f9369fa921e355 |
| publicationDate | 2010-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101641101-A |
| titleOfInvention | The method of treatment mood disorders |
| abstract | Treatment and following disease association but be not limited to and at least a symptom of following disease association or the method for disease, described disease is a mood disorders, include but not limited to a) depression, include but not limited to major depressive disorder and dysthymic disorder, b) two-phase depression of sex and/or two-phase mania, include but not limited to I type bipolar disorder, include but not limited to have maniac access, the I type bipolar disorder of paralepsy or mixing outbreak, with II type bipolar disorder, c) circulation affective disorders, and d) mood disorders that is caused by the general medicine disease, described method comprise the formula I compound or pharmaceutically acceptable salt thereof of effective dosage.Another aspect of the present invention provides pharmaceutical composition, and it comprises formula I compound or pharmaceutically acceptable salt thereof and at least a pharmaceutically suitable carrier or the diluent of effective dose. |
| priorityDate | 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 172.